Coya Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Coya Therapeutics's estimated annual revenue is currently $1.2M per year.
- Coya Therapeutics's estimated revenue per employee is $77,500
- Coya Therapeutics's total funding is $10M.
Employee Data
- Coya Therapeutics has 16 Employees.
- Coya Therapeutics grew their employee count by 23% last year.
Coya Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Business Development Officer | Reveal Email/Phone |
2 | President and Chief Medical Officer | Reveal Email/Phone |
3 | CFO/COO | Reveal Email/Phone |
4 | Chief Business Officer | Reveal Email/Phone |
5 | VP, Operations and Patient Advocacy | Reveal Email/Phone |
6 | VP, Operations and Patient Advocacy | Reveal Email/Phone |
7 | SVP Regulatory Affairs | Reveal Email/Phone |
8 | SVP Regulatory Affairs | Reveal Email/Phone |
9 | Director Clinical Development | Reveal Email/Phone |
10 | CFO and Chief Operating Officer | Reveal Email/Phone |
Coya Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is Coya Therapeutics?
The company's proprietary CTreg™ (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf' approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAI™ (Exosomes Against Inflammation) platforms , Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson's, Alzheimer's, FTD and autoimmune diseases.
keywords:N/A
$10M
Total Funding
16
Number of Employees
$1.2M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Coya Therapeutics News
Coya Therapeutics to Participate in B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference. ? Fireside Chat with B. Riley Research...
About Coya Therapeutics, Inc. Headquartered in Houston, TX, Coya Therapeutics is a clinical-stage biotechnology company developing first-in-...
A Houston company has emerged from stealth mode to announce a merger and a round of financing. Coya Therapeutics, a clinical-stage biotech startup that focuses on creating therapeutics for neurodegenerative and autoimmune diseases, announced that it has completed a merger with Nicoya Health Inc ...
-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel, M.D., internationally renowned researcher and neurologist- HOUSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya), a clin ...
Other Companies in Houston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 16 | N/A | N/A |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $3.1M | 16 | -33% | N/A |
#4 | $2.4M | 16 | 0% | N/A |
#5 | $1.4M | 16 | 0% | N/A |